The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 20 , ISSUE 9 ( September, 2019 ) > List of Articles


Pyroptosis and Oral Cancer

Piyush Jain

Citation Information : Jain P. Pyroptosis and Oral Cancer. J Contemp Dent Pract 2019; 20 (9):1001-1002.

DOI: 10.5005/jp-journals-10024-2682

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; The Author(s).


  1. Man SM, Karki R, et al. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 2017;277(1):61–75. DOI: 10.1111/imr.12534.
  2. Miao EA, Rajan JV, et al. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011;243(1):206–214. DOI: 10.1111/j.1600-065X.2011.01044.x.
  3. Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol 2001;9:113–114. DOI: 10.1016/S0966-842X(00)01936-3.
  4. Xia X, Wang X, et al. The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis 2019;10(9):1–3. DOI: 10.1038/s41419-019-1883-8.
  5. Wu CS, Chang KP, et al. ASC contributes to metastasis of oral cavity squamous cell carcinoma. Oncotarget 2016;7(31):50074–50085. DOI: 10.18632/oncotarget.10317.
  6. Wei Q, Mu K, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 2014;94:52–62. DOI: 10.1038/labinvest.2013.126.
  7. Yue E, Tuguzbaeva G, et al. Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine 2019;56:286–294. DOI: 10.1016/j.phymed.2018.09.223.
  8. Iriti M, Varoni EM. Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies. Nutrients 2013;5(7):2564–2576. DOI: 10.3390/nu5072564.
  9. Sarode G, Sarode SC, et al. Is oral squamous cell carcinoma unique in terms of intra-and inter-tumoral heterogeneity? Trans Res Oral Oncol 2017;2:11–16. DOI 10.1177/2057178X17703578.
  10. Nilendu P, Sarode SC, et al. Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance. Cell Oncol (Dordr) 2018;41(4):353–367. DOI: 10.1007/s13402-018-0388-2.
  11. Sarode SC, Sarode GS, et al. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol 2011;47(9):920–921. DOI: 10.1016/j.oraloncology.2011.06.005.
  12. Sarode SC, Sarode GS, et al. Oral potentially malignant disorders: precising the definition. Oral Oncol 2012;9(48):759–760. DOI: 10.1016/j.oraloncology.2012.02.025.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.